loadpatents
Patent applications and USPTO patent grants for GANSERT; Jennifer Lorraine.The latest application filed is for "use of oncolytic viruses in the neoadjuvant therapy of cancer".
Patent | Date |
---|---|
Use Of Oncolytic Viruses In The Neoadjuvant Therapy Of Cancer App 20220211784 - GANSERT; Jennifer Lorraine | 2022-07-07 |
Biomarkers For Cancer Therapeutics App 20210008135 - Gansert; Jennifer Lorraine ;   et al. | 2021-01-14 |
Compositions And Methods For Treating Liver Cancer App 20200353022 - GANSERT; Jennifer Lorraine ;   et al. | 2020-11-12 |
Treatment Of Triple Negative Breast Cancer Or Colorectal Cancer With Liver Metastases With An Anti Pd-l1 Antibody And An Oncolyt App 20200254037 - Kind Code | 2020-08-13 |
Combination therapy Grant 8,980,259 - Huang , et al. March 17, 2 | 2015-03-17 |
Combination therapy Grant 8,961,970 - Huang , et al. February 24, 2 | 2015-02-24 |
Combination Therapy App 20140023661 - Huang; Xizhong ;   et al. | 2014-01-23 |
Combination Therapy App 20130273061 - Huang; Xizhong ;   et al. | 2013-10-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.